AMN 2018 Proxy Statement

EXHIBIT B TO PROXY STATEMENT EXHIBIT B TO PROXY STATEMENT Non-GAAP Reconciliation for Consolidated AEBITDA For Purposes of 2017 Bonus Achievement (in thousands) Year Ended December 31, 2017 Revenue Nurse and allied solutions $1,238,543 Locum tenens solutions 430,615 Other workforce solutions 319,296 $1,988,454 Segment operating income (1) Nurse and allied solutions $ 182,792 Locum tenens solutions 51,422 Other workforce solutions 81,154 315,368 Unallocated corporate overhead (2) 58,954 AEBITDA (3) $ 256,414 Depreciation and amortization 32,279 Share-based compensation 10,237 Acquisition and integration costs 1,458 Interest expense, net, and other 19,677 Income from operations before income tax 192,763 Income tax expense 60,205 Net income $ 132,558 (in thousands) Year Ended December 31, 2017 AEBITDA $ 256,414 Adjustments (4) 6,997 Pre Bonus AEBITDA (5) $ 263,411 (1) Segment operating income represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, unallocated corporate overhead, acquisition and integration costs and share-based compensation expense. (2) Please note that the amount set forth in this line item excludes the amount set forth in the line item below entitled “acquisition and integration costs.” Acquisition and integration costs are a subset of unallocated corporate overhead. (3) AEBITDA represents net income plus interest expense (net of interest income) and other, income tax expense, depreciation and amortization, acquisition and integration costs, and share-based compensation expense. Management believes that AEBITDA provides an effective measure of our results, as it excludes certain items that management believes are not indicative of our operating performance and considers measures used in credit facilities. AEBITDA is not intended to represent cash flows for the period, nor has it been presented as an alternative to income from operations or net income as an indicator of operating performance. Although management believes that some of the items excluded from AEBITDA are not indicative of our operating performance, these items do impact the statement of comprehensive income, and management therefore utilizes AEBITDA as an operating performance measure in conjunction with GAAP measures such as net income. (4) The amount represents the adjustments to Adjusted EBITDA decided by the Compensation Committee for bonus calculation and payout only. In establishing Pre-Bonus Adjusted EBITDA targets at the beginning of the year, the Compensation Committee excludes from Adjusted EBITDA, the payout of bonuses and other extraordinary items not contemplated in the Company’s 2017 Ops Plan that should be excluded for bonus purposes. (5) Pre-bonus AEBITDA represents the adjustments made to AEBITDA decided by the Compensation Committee. AMN HEALTHCARE SERVICES, INC. ⎪ 2018 Proxy Statement B-1